NIH Begins Testing Mixed COVID-19 Vaccine Schedules
The U.S. National Institutes of Health (NIH) has announced that it has begun an early stage Phase 1/2 clinical trial to examining what happens when an adult who is fully vaccinated with one type of COVID-19 vaccine, is given a different booster vaccine from another manufacturer three to four months later.1 Currently, there are three […]
U.S. Government Partnering With Community Leaders to Increase COVID-19 Vaccine Uptake
The U.S. Department of Health and Human Services (HHS) has proposed an initiative called “The
Award Winning Investigative Journalist Provides Evidence of Origins of SARS-CoV-2
Although it has been suggested since the start of the pandemic in early 2020 that SARS-CoV-2, the new mutated coronavirus virus that causes COVID-19 disease, may have originated…
Moderna Expects $18.4 Billion in Sales from Its COVID-19 Vaccine This Year
Moderna, Inc. expects to generate $18.4 billion from sales of its experimental mRNA-1273 COVID-19 vaccine being distributed in the U.S. under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA). This will be the first time that the U.S. based pharmaceutical company will make a profit since it was established in […]
Moderna, Pfizer Test mRNA Experimental Biologics on Children
On Dec. 10, 2020, American biotechnology company Moderna, Inc., which is pioneering the development of experimental messenger RNA (mRNA) therapeutics and vaccines, gave a 12-year old a dose of the company’s mRNA-1273 vaccine in a Phase 2/3 study of the new vaccine. Moderna CEO Stephane Bancel said, “Our goal is to generate data in the […]
Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
What Does Zinc Bring to the Table?
Story Highlights Zinc is a trace element necessary for human health and has many important benefits including anti-inflammatory properties and powerful immune system support. It has long been used to reduce the duration and severity of the common cold, which is generally caused by coronaviruses. Zinc is not made by or stored in the body […]
AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]
COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials
The government of Canada has signed deals to purchase COVID-19 vaccines from four pharmaceutical companies when their vaccines are approved to be given to the public. According to Canada’s Minister of Public Services and Procurement Anita Anand, the Canadian government has contracts with Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Moderna, Novavax and Pfizer […]
Public Acceptance of COVID-19 Vaccine Faces Many Hurdles
Story Highlights Even before a vaccine against COVID-19 has been introduced to the public in the U.S., expectations for it are low. Dr. Anthony Fauci warns that a COVID-19 vaccine is not expected to be either long-lasting or more than 50 to 60 percent effective. Citing experience with other vaccines, a COVID-19 vaccine is not […]
